GenomicseLifePeer-reviewed
Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow
Sıla Gerlevik, Nogayhan Seymen, Shan Hama…·Mohammad Mahdi Karimi
The paper integrates inflammation, cell-type composition, and immune signatures in MDS to identify prognostic subgroups using MOFA, finding that high inflammation correlates with better prognosis while SRSF2 mutations are linked to poor outcomes.
2 citations